Insider Selling: 908 Devices Inc. (NASDAQ:MASS) Insider Sells 9,672 Shares of Stock

908 Devices Inc. (NASDAQ:MASS) insider Michael S. Turner sold 9,672 shares of the business’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $2.33, for a total value of $22,535.76. Following the completion of the transaction, the insider now directly owns 24,603 shares in the company, valued at approximately $57,324.99. This represents a 28.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

908 Devices Stock Down 3.8 %

908 Devices stock opened at $2.55 on Friday. 908 Devices Inc. has a one year low of $1.81 and a one year high of $7.91. The business has a fifty day moving average price of $2.35 and a 200-day moving average price of $3.26.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on MASS shares. Leerink Partnrs downgraded shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Stifel Nicolaus reduced their target price on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Weiss Ratings restated a “sell (e+)” rating on shares of 908 Devices in a research note on Saturday, February 1st. Stephens reiterated an “overweight” rating and issued a $6.00 price objective on shares of 908 Devices in a research note on Wednesday, January 15th. Finally, Leerink Partners restated a “market perform” rating and issued a $4.00 target price (down from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $5.33.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. 49 Wealth Management LLC grew its stake in 908 Devices by 16.2% during the third quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after acquiring an additional 4,343 shares in the last quarter. State Street Corp boosted its holdings in 908 Devices by 1.2% in the 3rd quarter. State Street Corp now owns 479,044 shares of the company’s stock valued at $1,662,000 after purchasing an additional 5,704 shares during the period. Geode Capital Management LLC grew its position in shares of 908 Devices by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 567,788 shares of the company’s stock valued at $1,970,000 after purchasing an additional 6,634 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of 908 Devices in the third quarter worth $36,000. Finally, B. Riley Wealth Advisors Inc. purchased a new stake in shares of 908 Devices in the third quarter worth $45,000. Hedge funds and other institutional investors own 88.06% of the company’s stock.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.